140.55
price down icon0.48%   -0.68
pre-market  Pre-market:  141.00   0.45   +0.32%
loading

Biogen Inc Stock (BIIB) Forecast

The Biogen Inc (BIIB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $276.97, representing a +97.06% increase from the current price of $140.55. The highest analyst price target is $296.34, and the lowest is $257.61.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BIIB Price Target
Average 187.46 (+33.38% Upside)
loading

Is Biogen Inc (BIIB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 29.25 Buy
STOCH(9,6) 11.74 Buy
STOCHRSI(14) 3.4247 Buy
MACD(12,26) -3.9005 Sell
ADX(14) 21.28 Neutral
William %R -96.94 Buy
CCI(14) -152.92 Sell
Buy: 4 Sell: 2 Neutral: 1
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
147.42
Sell
145.59
Sell
MA20
148.38
Sell
148.56
Sell
MA50
155.98
Sell
157.30
Sell
MA100
174.03
Sell
170.95
Sell
MA200
195.39
Sell
190.30
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, BIIB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on BIIB, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 29.25 indicates that BIIB is oversold. This indicates that BIIB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 11.74 indicates that BIIB is oversold. This indicates that BIIB price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.4247 indicates that BIIB is oversold. This suggests that BIIB price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 21.28 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -152.92 indicates that BIIB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term BIIB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Biogen Inc financial reports and earnings history, Biogen Inc (BIIB) stock could reach $216.78 by 2030, $276.39 by 2040 and $169.20 by 2050. See the projected annual prices until 2050 of the Biogen Inc stock below:

  • Biogen Inc (BIIB) is expected to reach an average price of $212.65 in 2035, with a high prediction of $232.20 and a low estimate of $201.56. This indicates an $51.30% rise from the last recorded price of $140.55.
  • Biogen Inc (BIIB) stock is projected to chart a bullish course in 2040, with an average price target of $275.12, representing an $95.75% surge from its current level. The forecast ranges from a conservative $244.27 to a sky-high $276.39.
  • Our analysts predict Biogen Inc (BIIB) to jump 55.73% by 2045, soaring from $155.43 to an average price of $218.88, potentially reaching $244.42. While $155.43 is the low estimate, the potential upside is significant.
  • Biogen Inc (BIIB) stock is expected to climb by 2050, reaching an average of $159.56, a $13.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $169.20 and $143.66, respectively, highlighting the market's uncertainty.

Biogen Inc Stock (BIIB) Year by Year Forecast

Biogen Inc Stock (BIIB) Price Forecast for 2025

Biogen Inc Stock (BIIB) is expected to reach an average price of $299.16 in 2025, with a high prediction of $365.00 and a low estimate of $233.33. This indicates an +112.85% rise from the last recorded price of $140.55.
Month Average Low High Change from today's price
February, 2025 $258.62 $257.61 $296.34 +84.00%
March, 2025 $294.78 $259.77 $365.00 +109.74%
April, 2025 $302.76 $252.45 $322.97 +115.41%
May, 2025 $331.80 $280.02 $340.27 +136.07%
June, 2025 $306.63 $281.91 $325.03 +118.17%
July, 2025 $261.59 $248.99 $313.54 +86.12%
August, 2025 $268.93 $247.66 $285.04 +91.34%
September, 2025 $295.76 $259.36 $302.05 +110.43%
October, 2025 $266.06 $264.08 $298.56 +89.30%
November, 2025 $273.75 $255.12 $278.02 +94.77%
December, 2025 $242.15 $233.33 $283.41 +72.28%

Biogen Inc Stock (BIIB) Price Forecast for 2026

The predicted value for Biogen Inc (BIIB) in 2026 is set at an average of $234.30. Estimates vary from a peak of $458.68 to a trough of $9.9227, indicating an +66.70% surge from the present price of $140.55.
Month Average Low High Change from today's price
January, 2026 $233.86 $9.9227 $354.00 +66.39%
February, 2026 $239.65 $229.64 $244.09 +70.51%
March, 2026 $265.93 $228.49 $272.69 +89.21%
April, 2026 $268.45 $251.07 $275.56 +91.00%
May, 2026 $257.18 $240.53 $278.18 +82.98%
June, 2026 $258.28 $253.61 $271.99 +83.77%
July, 2026 $270.33 $251.34 $273.28 +92.34%
August, 2026 $386.77 $254.25 $458.68 +175.18%
September, 2026 $348.30 $323.41 $400.53 +147.81%
October, 2026 $330.14 $307.39 $348.91 +134.89%
November, 2026 $329.06 $324.82 $342.00 +134.12%
December, 2026 $273.18 $272.79 $331.44 +94.37%

Biogen Inc Stock (BIIB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Biogen Inc (BIIB) is $229.14, with a high forecast of $280.92 and a low forecast of $177.37. This indicates an +63.03% increase from the last price of $140.55.
Month Average Low High Change from today's price
January, 2027 $254.96 $254.51 $280.92 +81.40%
February, 2027 $247.36 $242.19 $274.75 +75.99%
March, 2027 $227.60 $211.89 $249.06 +61.94%
April, 2027 $229.48 $207.28 $255.72 +63.27%
May, 2027 $211.72 $202.75 $229.09 +50.63%
June, 2027 $199.64 $190.55 $218.72 +42.05%
July, 2027 $200.80 $182.87 $208.42 +42.87%
August, 2027 $200.20 $195.72 $215.71 +42.44%
September, 2027 $196.41 $177.37 $205.79 +39.75%
October, 2027 $191.96 $178.76 $198.71 +36.58%
November, 2027 $209.03 $190.09 $211.01 +48.72%
December, 2027 $211.22 $194.41 $213.05 +50.28%

Biogen Inc Stock (BIIB) Price Forecast for 2028

In 2028, Biogen Inc (BIIB) is projected to reach an average price of $246.98, with a high projection of $310.07 and a low estimate of $183.89. This indicates an +75.72% rise from the last price of $140.55.
Month Average Low High Change from today's price
January, 2028 $186.27 $183.89 $212.74 +32.53%
February, 2028 $257.25 $184.66 $273.69 +83.03%
March, 2028 $273.69 $240.56 $275.60 +94.73%
April, 2028 $295.41 $264.89 $297.79 +110.18%
May, 2028 $269.43 $266.33 $302.14 +91.69%
June, 2028 $276.04 $255.59 $282.86 +96.40%
July, 2028 $276.58 $272.80 $286.17 +96.78%
August, 2028 $246.85 $245.09 $283.03 +75.63%
September, 2028 $277.09 $245.69 $278.06 +97.15%
October, 2028 $308.36 $265.20 $310.04 +119.39%
November, 2028 $290.51 $281.94 $307.78 +106.69%
December, 2028 $275.16 $268.02 $310.07 +95.78%

Biogen Inc Stock (BIIB) Price Forecast for 2029

The 2029 price forecast for Biogen Inc Stock (BIIB) is $228.87 on average, with a high prediction of $277.91 and a low estimate of $179.83. This represents an +62.84% increase from the previous price of $140.55.
Month Average Low High Change from today's price
January, 2029 $260.51 $246.45 $277.91 +85.35%
February, 2029 $254.76 $250.08 $269.27 +81.26%
March, 2029 $245.12 $244.33 $260.83 +74.40%
April, 2029 $252.60 $238.75 $258.78 +79.72%
May, 2029 $215.14 $211.74 $259.77 +53.07%
June, 2029 $224.99 $211.21 $225.46 +60.08%
July, 2029 $249.13 $219.51 $254.34 +77.25%
August, 2029 $237.03 $231.19 $258.66 +68.64%
September, 2029 $213.69 $206.05 $239.70 +52.04%
October, 2029 $208.48 $205.73 $220.60 +48.33%
November, 2029 $184.77 $179.83 $208.64 +31.46%
December, 2029 $206.07 $183.14 $216.49 +46.62%

Biogen Inc Stock (BIIB) Price Forecast for 2030

Biogen Inc Stock (BIIB) is expected to reach an average price of $275.37 in 2030, with a high forecast of $355.01 and a low forecast of $195.72. This signifies an +95.92% surge from the last price of $140.55.
Month Average Low High Change from today's price
January, 2030 $207.90 $199.50 $216.78 +47.92%
February, 2030 $210.97 $206.89 $224.66 +50.10%
March, 2030 $222.21 $208.50 $226.91 +58.10%
April, 2030 $199.48 $197.84 $220.92 +41.93%
May, 2030 $213.06 $195.72 $222.45 +51.59%
June, 2030 $268.91 $199.71 $297.97 +91.33%
July, 2030 $279.98 $251.46 $286.88 +99.21%
August, 2030 $281.46 $255.03 $289.05 +100.25%
September, 2030 $276.43 $267.82 $286.94 +96.68%
October, 2030 $312.78 $247.62 $355.01 +122.54%
November, 2030 $276.29 $246.05 $324.03 +96.57%
December, 2030 $277.63 $242.47 $301.24 +97.53%
$91.84
price up icon 0.21%
drug_manufacturers_general SNY
$50.74
price up icon 0.00%
$272.11
price up icon 0.99%
drug_manufacturers_general PFE
$26.30
price down icon 0.72%
drug_manufacturers_general NVS
$97.53
price down icon 0.34%
drug_manufacturers_general MRK
$97.92
price down icon 2.76%
Cap:     |  Volume (24h):